Contact
Manon Navez
Email
+32 (0)471 54 76 33
Osivax is a clinical-stage biotechnology company that uses its oligoDOM™ technology platform to develop innovative vaccines. Osivax's main project is a universal influenza vaccine that aims to revolutionize the prevention of seasonal influenza, currently in Phase 2a. Osivax is using this same technology to develop a broad-spectrum vaccine against SARS-COV-2, its variants or a new coronavirus pandemic.
For more information, please visit their website : www.osivax.com
Osivax has offices in France (Headquarters in Lyon) and Belgium (Affiliate in Liège). It is a growing company with over 40 employees. Their offices in Liège host about 10 employees including Clinical Operations and a Quality Control laboratory.
As part of the development of their clinical trials in Europe and worldwide, we are looking for a: Intern – in-house Clinical Research Associate – Liège (M/F)
Reporting to the Clinical Operations Manager, you will join and support the Clinical Operations team in the deployment of clinical trials at both local and international levels. You will contribute to the success of innovative vaccine research from initiation to closure.
Your main responsibilities are:
Your application and related information will remain strictly confidential.